AFRAVIH 2026 in Lausanne: HIV Fight Under Trump's Shadow

The 2026 AFRAVIH conference in Lausanne addresses HIV/AIDS challenges amid US funding cuts under Trump's policies.

AFRAVIH 2026 in Lausanne: HIV Fight Under Trump's Shadow

Image: vih.org

The 2026 AFRAVIH conference, held in Lausanne from May 12-15, brings together French-speaking HIV/AIDS researchers and activists. This year's event focuses on the impact of US funding cuts under President Trump's administration, which have reduced contributions to global health initiatives like PEPFAR and the Global Fund.

Organizers emphasize the conference's in-person format to foster collaboration, despite economic pressures. Key topics include antiretroviral access in Africa, stigma reduction, and the rise of HIV drug resistance. According to UNAIDS, global HIV funding gaps could jeopardize progress toward ending AIDS by 2030.

Speakers include Dr. Françoise Barré-Sinoussi, Nobel laureate, who warned that political shifts threaten decades of progress. The conference also highlights community-led responses and the need for sustainable domestic financing in affected countries.

❓ Frequently Asked Questions

What is AFRAVIH?

AFRAVIH is a French-language international conference on HIV/AIDS, held annually to discuss research, treatment, and policy.

How have Trump's policies affected HIV funding?

Trump's administration reduced US contributions to global health programs like PEPFAR and the Global Fund, creating funding gaps for HIV treatment and prevention.

What are the main challenges discussed at AFRAVIH 2026?

Key challenges include antiretroviral access in Africa, rising drug resistance, stigma, and the impact of US funding cuts on global AIDS targets.

📰 Source:
vih.org →
Share: